AI-generated summary
The authors used fMRI to examine whether transcranial photobiomodulation with an 810 nm device changes four major resting-state brain networks in 20 young adults. They compared scans after active and sham sessions and reported no substantial differences in any network, indicating no clear photobiomodulation effect. The authors suggest the effect may only become apparent when brain circuitry is altered, such as in pathology, ageing or task engagement.
- Participants
- 20
- Who or what was studied
- Normal young adults (mean age 30.0 ± 2.8 years)
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The abstract describes a small sample of 20 subjects and does not report a stated sham-controlled effect size or statistical detail, and the authors themselves note the effect may only be clear in altered brain states.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Functional magnetic resonance imaging, Sham, Transcranial photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.